Mar 28, 2013, 07.37 PM | Source: CNBC-TV18
According to Parag Doctor, Head - Trading Strategies at Keynote Capital, investor can hold Aurobindo Pharma with a target price of Rs 180-200 over the next one year.
Parag Doctor (more)
Head - Trading Strategies, LKP | Capital Expertise: Equity - Fundamental
Doctor told CNBC-TV18, “The rally which has started today it is more of a short-term pullback rally in Aurobindo Pharma. The 200-day average is around the Rs 150-160 kind of levels, where we expect the immediate upside. Further base building is likely in the stock between Rs 130 and Rs 150 and once that process is done then we expect higher levels between Rs 180 and Rs 200 over the next year or so. So, the investor can hold on with those targets in mind.”
Aurobindo Pharma has inked a pact to acquire selec
Over the past few months, US FDA has given a go-ah
Ashwani Gujral of ashwanigujral.com is of the view